1,022
Views
18
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Stakeholder perspectives on the stigma of fetal alcohol spectrum disorder

, , , , , & show all
Pages 170-177 | Received 24 Feb 2018, Accepted 16 May 2018, Published online: 18 Jun 2018
 

Abstract

Background: Fetal Alcohol Spectrum Disorder (FASD) is a condition afflicting children born to women who consumed alcohol during pregnancy that can lead to secondary disabilities including cognitive and social deficits. Both, children with FASD, and their biological mothers, are targets of FASD stigma. This study seeks to identify stereotypes, prejudice, and discrimination corresponding to FASD stigma.

Methods: Nine stakeholders comprised a community based participatory research (CBPR) team to discuss logistics, identify focus groups, and develop a qualitative interview guide. Attitudes and beliefs regarding children with FASD and their biological mothers were obtained from four focus groups of people: adults with FASD, biological mothers, other relatives, and health care providers. In addition, three one-on-one interviews were completed. Responses were coded into themes by two independent raters.

Results: Analyses yielded themes that distinguished between stigmatizing perceptions of children with FASD (e.g., immature, lazy, violent, socially inept) and biological mothers (e.g. child abusers, in denial, secretive, ignorant). Discrimination perpetuated by health care providers undermined services received by biological mothers and their children with FASD (e.g., lack of understanding, lack of identification, poor communication skills). Lastly, discriminatory behaviors specific to children with FASD and their biological mothers were identified (e.g., neglect, avoidance, abuse).

Conclusion: Results described the stigma experienced by different stakeholders related to FASD by identifying specific candidates for stereotypes, prejudice, and discrimination. These findings can be used to inform further assessment of stigma and also the development of tailored anti-stigma interventions.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Centers for Disease Control and Prevention (CDC) under Grant number NU01DD001144.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.